Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian CarcinomaJune Y. Hou(Montefiore Medical Center), Hayley M. McDaid(Albert Einstein College of Medicine)PLoS ONEFebruary 4, 201310.1371/journal.pone.0054103Cited by 27SaveCiteExport RISWatch citationsRelated PapersEnhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human Heterotransplants|Cancer Research|2005|90